The leishmaniases consist of visceral and cutaneous syndromes present in > 30 endemic regions of the world. Miltefosine (hexadecylephosphocholine) is the first oral agent that is effective and tolerated for both visceral and cutaneous disease in several endemic regions, and represents a major advance in the treatment of these diseases.
No takes yet. Share an insight, caveat, or question.
J D Berman (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: